CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) H-1B Visa Sponsorship & Salary Data

The median H-1B salary at CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) is $88,100, based on 49 certified filings from FY 2021 to FY 2023. This is 27% lower than the national H-1B median salary of $120,000. Compensation at CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) reflects their market positioning, with entry-level roles starting around $79,958 and senior positions reaching $150,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) range from $66,000 at the 10th percentile to $150,000 at the 90th percentile, showing a $84,000 spread across experience levels and roles. The 25th percentile is $79,958 and the 75th percentile is $110,000.

Yes, CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 63 H-1B labor condition applications from FY 2021 to FY 2023, demonstrating ongoing commitment to hiring international talent. With 49 certified applications and a 0% denial rate, CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2023), CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) filed 15 H-1B applications, with 14 certified and 0 denied. Over 3 years of data, CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .)'s LCA (Labor Condition Application) denial rate is 0%, with 0 out of 63 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) as a potential H-1B sponsor.

This is an excellent approval rate, indicating CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 49 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .):

The most frequently sponsored role is Senior Research Scientist with 8 filings at a median salary of $85,000. This is followed by Research Scientist II (3 filings) and Senior Quality Assurance Specialist.

CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .)'s H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) H-1B locations:

The largest H-1B hub for CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) is Burlington, MA with 11 filings at a median salary of $110,000. The highest-paying location is Burlington, MA at $110,000 median. Salaries range from $57,991 to $110,000 across office locations.

CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .)'s median H-1B salary has changed by -29% from FY 2021 ($120,000) to FY 2023 ($85,000). Tracking salary trends over time reveals how CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .).

Year-by-year breakdown:

• FY 2021: $120,000 (2 certified)
• FY 2022: $89,250 (33 certified)
• FY 2023: $85,000 (14 certified)

Salary levels have remained relatively stable at CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .).

CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) primarily files H-1B applications at Wage Level II, accounting for 33% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .)'s wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .)'s median H-1B salary of $88,100 is 27% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .)'s competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .)'s offerings with similar companies in your field for a more accurate assessment.

CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .)'s H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) files 27% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 49 certified filings, CURIA GLOBAL, . (FORMERLY ALBANY MOLECULAR RESEARCH, .) invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.